Key stats
About Ark Genomic Revolution Ucits ETF AccumUSD
Expense ratio
0.79%
Home page
Inception date
Apr 12, 2024
ISIN
IE000O5M6XO1
The investment objective of the Fund is to generate long term capital growth (5 years or more)
Classification
What's in the fund
Exposure type
Health Technology
Technology Services
Stock breakdown by region
Displays a symbol's price movements over previous years to identify recurring trends.